Articles

Videos

Podcasts

Clinical

Beyond the benefits to the pharmacist profession, granting provider status to pharmacists addresses the larger societal problem of growing physician shortages.

The Societal Case for Pharmacist Provider Status

Formulary changes, utilization management, and a lack of transparency upset a lot of members, which hides a lot of good things that pharmacy benefit managers do.

How PBMs Can Help Rein in Drug Spending

Concepts could be used in payer-pharmacy value-based arrangements.

PQA and CPF Lead National Initiative to Prioritize Pharmacy Measure Concepts

As specialty drugs move through clinical trials and preparations for commercialization begin, significant attention is warranted to this process considering the massive investments that would have been already made in the product up to this point.  

Specialty Drug Commercialization Process and Considerations

Pharmacy Times spoke with Dr. Trishia Shaw, the Clinical Assistant Professor of Pharmacy Practice at Chicago State University College of Pharmacy, on her presentation at the NPhA conference titled “Who’s your Provider”—Updates in Provider Status for Pharmacists.

Updates in Provider Status for Pharmacists

As the price tags for therapies coming to market have soared into the hundreds of thousands and even millions on occasion, paying for them has become an ever-greater cause of concern and focus area. 

Examining the True Cost of Carve-out Savings: Quality Clinical Care

As health care costs rise and cost-sharing increases, treatment-associated expenses will continue to burden patients.

Breast Cancer, Financial Toxicity, and the Role of Specialty Pharmacy in Reducing Barriers to Care

CMS reported that 3.3 million more Medicare Part D beneficiaries with complex health needs than expected between 2013-2018 received a comprehensive medication review as a part of medication therapy management

Medication Adherence Measures Help Medicare Beneficiaries Avoid Up to $46.6 Billion in Health Care Costs

HDHPs require patients to pay for all care out of pocket until the plan’s deductible is reached, and only after this threshold does insurance start to cover medical costs.

Study: Diabetes Patients in High-Deductible Health Plans More Likely to Skip Medications

Antonio Ciaccia, CEO of 46brooklyn Research, discusses his company’s efforts to uncover and understand the structure that underlies US drug pricing distortions. 

Reimbursement